|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
150 Cambridgepark Dr,Cambridge,Massachusetts,US
|
|
GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.
|
GentiBio Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used GentiBio email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact GentiBio customer service number in your country click here to find.
Adel Nada is the CEO of GentiBio. To contact Adel Nada email at [email protected] or [email protected]. Or you may call +1 224 250 0797
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.